These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 26211824)

  • 1. Adjuvant bisphosphonate treatment in early breast cancer: meta-analyses of individual patient data from randomised trials.
    Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
    Lancet; 2015 Oct; 386(10001):1353-1361. PubMed ID: 26211824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bisphosphonates and other bone agents for breast cancer.
    O'Carrigan B; Wong MH; Willson ML; Stockler MR; Pavlakis N; Goodwin A
    Cochrane Database Syst Rev; 2017 Oct; 10(10):CD003474. PubMed ID: 29082518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bisphosphonates for breast cancer.
    Pavlakis N; Schmidt R; Stockler M
    Cochrane Database Syst Rev; 2005 Jul; (3):CD003474. PubMed ID: 16034900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aromatase inhibitors versus tamoxifen in early breast cancer: patient-level meta-analysis of the randomised trials.
    Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
    Lancet; 2015 Oct; 386(10001):1341-1352. PubMed ID: 26211827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant zoledronic acid in patients with early breast cancer: final efficacy analysis of the AZURE (BIG 01/04) randomised open-label phase 3 trial.
    Coleman R; Cameron D; Dodwell D; Bell R; Wilson C; Rathbone E; Keane M; Gil M; Burkinshaw R; Grieve R; Barrett-Lee P; Ritchie D; Liversedge V; Hinsley S; Marshall H;
    Lancet Oncol; 2014 Aug; 15(9):997-1006. PubMed ID: 25035292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1998 Sep; 352(9132):930-42. PubMed ID: 9752815
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bisphosphonates and other bone agents for breast cancer.
    Wong MH; Stockler MR; Pavlakis N
    Cochrane Database Syst Rev; 2012 Feb; (2):CD003474. PubMed ID: 22336790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. WITHDRAWN: Multi-agent chemotherapy for early breast cancer.
    Clarke MJ
    Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD000487. PubMed ID: 18843612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multi-agent chemotherapy for early breast cancer.
    Early Breast Cancer Trialists' Collaborative Group
    Cochrane Database Syst Rev; 2002; (1):CD000487. PubMed ID: 11869577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bisphosphonates for breast cancer.
    Pavlakis N; Stockler M
    Cochrane Database Syst Rev; 2002; (1):CD003474. PubMed ID: 11869664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparisons between different polychemotherapy regimens for early breast cancer: meta-analyses of long-term outcome among 100,000 women in 123 randomised trials.
    ; Peto R; Davies C; Godwin J; Gray R; Pan HC; Clarke M; Cutter D; Darby S; McGale P; Taylor C; Wang YC; Bergh J; Di Leo A; Albain K; Swain S; Piccart M; Pritchard K
    Lancet; 2012 Feb; 379(9814):432-44. PubMed ID: 22152853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Does adjuvant bisphosphonate in early breast cancer modify the natural course of the disease? A meta-analysis of randomized controlled trials.
    Mauri D; Valachis A; Polyzos NP; Tsali L; Mavroudis D; Georgoulias V; Casazza G
    J Natl Compr Canc Netw; 2010 Mar; 8(3):279-86. PubMed ID: 20202461
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Bisphosphonates in Breast Cancer Therapy.
    Goldvaser H; Amir E
    Curr Treat Options Oncol; 2019 Mar; 20(4):26. PubMed ID: 30874905
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.
    Lancet; 1998 May; 351(9114):1451-67. PubMed ID: 9605801
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WITHDRAWN: Tamoxifen for early breast cancer.
    Clarke MJ
    Cochrane Database Syst Rev; 2008 Oct; 2008(4):CD000486. PubMed ID: 18843611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tamoxifen for early breast cancer.
    Early Breast Cancer Trialists' Collaborative Group
    Cochrane Database Syst Rev; 2001; (1):CD000486. PubMed ID: 11279694
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increasing the dose intensity of chemotherapy by more frequent administration or sequential scheduling: a patient-level meta-analysis of 37 298 women with early breast cancer in 26 randomised trials.
    Early Breast Cancer Trialists' Collaborative Group (EBCTCG)
    Lancet; 2019 Apr; 393(10179):1440-1452. PubMed ID: 30739743
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical benefits of bone targeted agents in early breast cancer.
    Coleman R
    Breast; 2019 Nov; 48 Suppl 1():S92-S96. PubMed ID: 31839171
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trial.
    Coleman R; Hall A; Albanell J; Hanby A; Bell R; Cameron D; Dodwell D; Marshall H; Jean-Mairet J; Tercero JC; Rojo F; Gregory W; Gomis RR
    Lancet Oncol; 2017 Nov; 18(11):1543-1552. PubMed ID: 29037984
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bisphosphonate Use and Risk of Recurrence, Second Primary Breast Cancer, and Breast Cancer Mortality in a Population-Based Cohort of Breast Cancer Patients.
    Korde LA; Doody DR; Hsu L; Porter PL; Malone KE
    Cancer Epidemiol Biomarkers Prev; 2018 Feb; 27(2):165-173. PubMed ID: 29254937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 32.